enGenome

Private

PaviaHealthcare & Life Scienceshttps://engenome.com/

Last Round

Accelerator

Oct 14, 2021

Total Funding Raised

$4.29M

Company Overview

enGenome is a bioinformatics company that provides an AI-powered software platform for genomic data analysis and interpretation to support the diagnosis of genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Precision Medicine, Biotechnology, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Freemium

AI Layer

Application

Keywords

genomic data interpretationAI for genomicsvariant interpretationrare disease diagnosisbioinformatics platformNGS data analysisvariant classificationhereditary diseaseACMG guidelinesclinical decision supportCE-IVD softwareexplainable AIXAIgenerative AIgenomic literature searchbioinformatics consulting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

enGenome Comparables

Compare enGenome with similar companies based on industry and business-model similarity.

enGenome comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Limbus Medical Technologies	88%
Saphetor	88%
SeqOne	82%

View all Comparables

enGenome Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Oct 14, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Ivan Limongelli

CTO & Co Founder

Founding Team

Ettore Rizzo

CEO and Co Founder

Founding Team

enGenome Investors

Notable investors and investment history

enGenome investors
Investor	Rounds
European Innovation Council Fund	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 9, 2025
Monthly visitors increased 64% MoM, reaching 5.8K.
Jun 1, 2025
Monthly visitors increased 41% MoM, reaching 3.1K.

View all signals

enGenome Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

enGenome Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about enGenome's valuation, stock price, and market status.

Firmographic Details

HeadquartersPavia

Employee Range25

Year Founded2016

Last FundingOct 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?